Showing 1011-1020 of 1645 results for "".
- 10 Tips for Managing Adolescent Epilepsyhttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/pn0308-epilepsy-fea-pdf/31041/Managing Epilepsy in Adolescents: Addressing Unique Challenges for Optimal OutcomesEpilepsy management in adolescents presents distinct challenges that transcend typical age-related barriers, necessitating tailored approaches for effective treatment. As highlighted in the March 2008 issue of *Practi
- Will Generics Gobble Up The Neurology Market?https://practicalneurology.com/columns/practice-management/will-generics-gobble-up-the-neurology-market/31082/Generics Gain Ground in Neurology: Implications for Clinical PracticeThe landscape of neurology pharmacotherapy is shifting as generic medications increasingly replace brand-name drugs, promising substantial cost savings without compromising efficacy. As highlighted in the December 2007 issue of *Pr
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/pn1107painmanagement-pdf/31103/Defining Neuropathic Pain: Challenges and Screening Tools for Clinical PracticeNeuropathic pain, a pivotal element in the pathophysiology of chronic pain, remains challenging to define and diagnose accurately. This complexity arises from its dual presentation of positive symptoms, such as burning pa
- Vascular Clinichttps://practicalneurology.com/columns/practice-management/vascular-clinic/31171/Thrombolytic therapy for acute ischemic stroke, specifically tissue plasminogen activator (tPA), remains significantly underutilized, with treatment rates persisting below five percent despite robust evidence supporting its efficacy and safety. Since the FDA approved tPA for stroke in 1996, multiple
- Movement Disorders Focushttps://practicalneurology.com/diseases-diagnoses/movement-disorders/pn0407-movemntdis-pdf/31190/Tardive Dyskinesia: Overview, Causes, and ManagementTardive dyskinesia (TD) represents a complex group of involuntary, repetitive movements primarily resulting from prolonged use of dopamine-receptor antagonists (DRAs), including both typical and atypical antipsychotic medications. TD is characteriz
- Protecting Stroke Patients from Seizureshttps://practicalneurology.com/diseases-diagnoses/stroke/pn0407-post-stroke-pdf/31194/Post-Stroke Seizures: Epidemiology, Classification, and ManagementAs the global population ages, the incidence of post-stroke seizures is expected to rise, highlighting their clinical significance in neurology. Stroke markedly increases the risk of seizures, with a 23- to 35-fold higher incidence co
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/PN1206painmngmt-pdf/31240/Identifying Pharmacologic Triggers in Migraine Management: Insights from Clinical CasesMigraine management poses significant challenges, particularly when pharmacologic interventions inadvertently exacerbate headache disorders. Dr. Charles Argoff’s article in *Practical Neurology* explores this issu
- Business Advisorhttps://practicalneurology.com/columns/practice-management/business-advisor/31250/Effective telephone management is crucial for neurology practices to maintain strong communication with patients and referring providers. In the November 2006 issue of *Practical Neurology*, Craig T. Williams emphasizes the importance of optimizing phone systems to enhance patient satisfaction and s
- Stay Alert for Signs of Sleep Apneahttps://practicalneurology.com/diseases-diagnoses/sleep/PN1006SleepApnea-pdf/31266/Expanding Understanding of Obstructive Sleep Apnea Syndrome (OSAS)Obstructive Sleep Apnea Syndrome (OSAS) presents a broader clinical spectrum than the traditional portrayal of an obese, snoring male. Epidemiological data reveal that OSAS affects individuals across all age groups, with the highest i
- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0706dementia-pdf/31292/Evolving Classification and Diagnostic Challenges in Frontotemporal DementiaFrontotemporal dementia (FTD), historically referred to as Pick’s disease, remains a complex and evolving entity in neurology. Initially described by Arnold Pick in 1892, Pick’s disease was characterized by symptoms such as